1. Home
  2. TMDX vs CORT Comparison

TMDX vs CORT Comparison

Compare TMDX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$129.52

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$38.49

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
CORT
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.7B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TMDX
CORT
Price
$129.52
$38.49
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
$144.25
$114.20
AVG Volume (30 Days)
753.2K
2.0M
Earning Date
02-24-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
170.70
N/A
EPS
2.54
0.87
Revenue
$566,354,000.00
$741,172,000.00
Revenue This Year
$38.73
$23.09
Revenue Next Year
$20.55
$29.62
P/E Ratio
$52.56
$46.75
Revenue Growth
41.20
17.92
52 Week Low
$62.07
$32.99
52 Week High
$156.00
$117.33

Technical Indicators

Market Signals
Indicator
TMDX
CORT
Relative Strength Index (RSI) 43.77 36.31
Support Level $127.00 $38.10
Resistance Level $140.72 $41.92
Average True Range (ATR) 6.68 2.14
MACD -0.70 1.03
Stochastic Oscillator 13.23 16.96

Price Performance

Historical Comparison
TMDX
CORT

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: